RGD-modified PEG-PAMAM-DOX conjugate: in vitro and in vivo targeting to both tumor neovascular endothelial cells and tumor cells (Q39584202)

13 September 2017

RGD-modified PEG-PAMAM-DOX conjugate: in vitro and in vivo targeting to both tumor neovascular endothelial cells and tumor cells (English)

1 reference

13 September 2017

0 references

Saijie Zhu

1

1 reference

13 September 2017

Lili Qian

2

1 reference

13 September 2017

Minghuang Hong

3

1 reference

13 September 2017

Lihong Zhang

4

1 reference

13 September 2017

Yuanying Pei

5

1 reference

13 September 2017

Yanyan Jiang

6

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 March 2011

1 reference

13 September 2017

1 reference

13 September 2017

23

1 reference

13 September 2017

12

1 reference

13 September 2017

H84-9

1 reference

Imaging of integrins as biomarkers for tumor angiogenesis

13 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201003944

RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201003944

Biodistribution of HPMA copolymer-aminohexylgeldanamycin-RGDfK conjugates for prostate cancer drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201003944

Polyplex micelles with cyclic RGD peptide ligands and disulfide cross-links directing to the enhanced transfection via controlled intracellular trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201003944

PEGylated PAMAM dendrimer-doxorubicin conjugates: in vitro evaluation and in vivo tumor accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201003944

Partly PEGylated polyamidoamine dendrimer for tumor-selective targeting of doxorubicin: the effects of PEGylation degree and drug conjugation style

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201003944

Human tumor extracellular pH as a function of blood glucose concentration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201003944

Endocytosis and Signal Transduction: Basic Science Update

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201003944

A tumor-acidity-activated charge-conversional nanogel as an intelligent vehicle for promoted tumoral-cell uptake and drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201003944

RGD dendron bodies; synthetic avidity agents with defined and potentially interchangeable effector sites that can substitute for antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201003944

Cationic albumin-conjugated pegylated nanoparticles allow gene delivery into brain tumors via intravenous administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201003944

cRGD-functionalized polymer micelles for targeted doxorubicin delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201003944

Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201003944

The effect of surface functionality on cellular trafficking of dendrimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201003944

Efficient tumor targeting of hydroxycamptothecin loaded PEGylated niosomes modified with transferrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201003944

Folate receptor targeted bimodal liposomes for tumor magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201003944

The use of RGDGWK-lipopeptide to selectively deliver genes to mouse tumor vasculature and its complexation with p53 to inhibit tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201003944

Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201003944

Evaluation of biodistribution and anti-tumor effect of a dimeric RGD peptide-paclitaxel conjugate in mice with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201003944

Tumor endothelial markers: new targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201003944

Polyacetal−Doxorubicin Conjugates Designed for pH-Dependent Degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201003944

Enhanced intracellular delivery and improved antitumor efficacy of doxorubicin by sterically stabilized liposomes modified with a synthetic RGD mimetic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201003944

21 January 2018

Identifiers

DOI

10.1002/ADMA.201003944

1 reference

release_ephleu2h2zboreimt6mgxsu55a

13 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ephleu2h2zboreimt6mgxsu55a

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference